GSK3β: A Master Player in Depressive Disorder Pathogenesis and Treatment Responsiveness
Open accessThe DOI matches its Crossref record; 211 of the 211 references it cites were found in a registry or an index.
Abstract
Glycogen synthase kinase 3β (GSK3β), originally described as a negative regulator of glycogen synthesis, is a molecular hub linking numerous signaling pathways in a cell. Specific GSK3β inhibitors have anti-depressant effects and reduce depressive-like behavior in animal models of depression. Therefore, GSK3β is suggested to be engaged in the pathogenesis of major depressive disorder, and to be a target and/or modifier of anti-depressants’ action. In this review, we discuss abnormalities in the activity of GSK3β and its upstream regulators in different brain regions during depressive episodes. Additionally, putative role(s) of GSK3β in the pathogenesis of depression and the influence of anti-depressants on GSK3β activity are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Treatment with GSK-3β inhibitors reduces the production of QUIN and subsequently alleviates depressive, anxious, and aggressive behaviors in animal models (137).”
From Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories (2023) · cites this paper as [137]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly, post-mortem studies have reported elevated GSK-3β mRNA levels in the hippocampus of patients with major depression.”
From Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories (2023) · cites this paper as [137]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–211 of 211
Levchenko, А., Losenkov, I. S., Vyalova, N. M., Simutkin, G. G., Bokhan, N. A., Wilffert, B., LOONEN, A. J. M., & Ivanova, S. А. (2018) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s171423 · Cited by 22 · cited 1×
“rs334558, a promoter SNP related with enhanced GSK3β transcription [57], is associated with remission upon anti-depressant drugs administration [60].”
BackgroundLiu, S., Sun, N., Xu, Y., Yang, C., Ren, Y., Liu, Z., Cao, X., Sun, Y., Xu, Q., Zhang, K., et al. (2012) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2012.0227 · Cited by 21 · cited 1×
“Additionally, rs6438552, together with rs334558, has been linked to anxiety-like behavior in MDD [59].”
BackgroundBorumand, M. R., Motaghinejad, M., Motevalian, M., & Gholami, M. (2019) · PubMed Central · doi:10.30476/ijms.2019.44515 · Cited by 19 · cited 1×
“Members of the SSNRIs group, atomoxetine and milnacipran, induce AKT by increasing its activatory phosphorylation [184,185], whereas duloxetine stimulates expression of AKT and inhibits expression of both GSK3 isozymes [186].”
BackgroundChang, P.-K., Chu, J., Tsai, Y.-T., Lai, Y.-H., & Chen, J. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-019-0613-y · Cited by 19 · cited 2×
“Moreover, inhibition or knockdown of GSK3β, but not the α isozyme, in the medial PFC of wild-type mice impairs recognition memory [160], which suggests that in the medial PFC, D3R acts via GSK3β signaling to play a role in the novel objects recognition memory.”
BackgroundLithium Salts in the Treatment of Psychotic Excitement
Cade, J. F. (1982) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048678209159969 · Cited by 17 · cited 1×
“In 1949, Cade suggested that lithium, the classical mood stabilizer, might be a possible therapeutic for psychiatric diseases based on its behavioral effects in guinea pigs [62].”
BackgroundReisi, P., Eidelkhani, N., Rafiee, L., Kazemi, M., Radahmadi, M., & Alaei, H. (2017) · Research in Pharmaceutical Sciences · doi:10.4103/1735-5362.199042 · Cited by 12 · cited 1×
“However, it is known that chronic administration of doxepin does not alter AKT gene expression in rodent hippocampus [169,170].”
BackgroundBaşar, K., Eren-Koçak, E., Ozdemir, H., & Ertugrul, A. (2013) · Journal of ECT · doi:10.1097/yct.0b013e318290f7ff · Cited by 10
Li, S., Wei, Y.-M., Shi, H., Luo, Y., Ding, Z., Xue, Y.-X., Lü, L., & Yu, C. (2013) · Addiction Biology · doi:10.1111/adb.12068 · Cited by 7 · cited 1×
“Interestingly, it has been found that the level of Ser9-phosphorylated GSK3β in the ventral tegmental area and other reward-related brain structures in naïve rats shows significant circadian rhythmicity [52].”
BackgroundReisi, P., Eidelkhani, N., Radahmadi, M., Kazemi, M., Rafiee, L., & Alaei, H. (2015) · Advanced Biomedical Research · doi:10.4103/2277-9175.166139 · Cited by 5 · cited 1×
“However, it is known that chronic administration of doxepin does not alter AKT gene expression in rodent hippocampus [169,170].”
BackgroundMechanism underlying the effects of doxepin on β-amyloid -induced memory impairment in rats.
Bu, J., & Zu, H. (2017) · PubMed Central · doi:10.22038/ijbms.2017.9274 · Cited by 5 · cited 1×
“On the other hand, in the rat model of Alzheimer’s disease, doxepin reverses the effect of soluble amyloid β 1-42-induced memory impairment acting through the PI3K/AKT/mTOR signaling pathway [171].”
BackgroundEffect of desipramine on gene expression in the mouse frontal cortex – Microarray study
Solich, J., Kolasa, M., Kuśmider, M., Faron‐Górecka, A., Pabian, P., Szafran‐Pilch, K., Żurawek, D., & Dziedzicka‐Wasylewska, M. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2014.09.001 · Cited by 4 · cited 1×
“One week of desipramine administration significantly lowers the expression of GSK3β gene in the mouse frontal cortex [166].”
Background
Cited by
Hassamal, S. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1130989 · Cited by 578
Molecular pathways of major depressive disorder converge on the synapse
Fries, G. R., Saldana, V. A., Finnstein, J., & Rein, T. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01806-1 · Cited by 504
“Polyamines such as spermidine, spermine, putrescine and agmatine are short, aliphatic amines that impact several pathways and synaptic activity by a variety of mechanisms; the impacted molecules and pathways include almost all systems mentioned in this review, e.g., Na+-, K+- and Ca2+-channels, 5-HT, NMDA, AMPA, kaina…”
BackgroundXiao, Z., Cao, Z., Yang, J., Jia, Z., Du, Y., Sun, G., Lu, Y. F., & Pei, L. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114594 · Cited by 76
Glycogen Synthase Kinase 3: Ion Channels, Plasticity, and Diseases
Marosi, M., Arman, P., Aceto, G., D’Ascenzo, M., & Laezza, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084413 · Cited by 46
“Herein, we provide an overview of the mechanisms by which GSK3β mediates direct and indirect effects on Nav and Kv channels with implications for neuronal excitability, plasticity, and ultimately vulnerability to neuropsychiatric disorders [34,53,56,58,59].”
BackgroundUrkon, M., Ferencz, E., Szász, J. A., Szabó, M. I. M., Orbán-Kis, K., Szatmári, S., & Nagy, E. E. (2025) · Pharmaceuticals · doi:10.3390/ph18050614 · Cited by 44
“In addition, enhanced BDNF signaling or TNF α reduction could also contribute to Akt/GSK-3 β regulation [185].”
Metadata
- Authors
- Duda, P., Hajka, D., Wójcicka, O., Rakus, D., & Gizak, A.
- Affiliations
- University of Wrocław (PL)
- Corresponding author
- Duda, Przemysław
- Gizak, Agnieszka
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2020-03-16
- Volume
- 9
- Issue
- 3
- Pages
- 727
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC7140610
- OpenAlex
- W3012493302
- Cited by
- 84
- References
- 211
- Citations by year
- 2026: 15 · 2025: 20 · 2024: 11 · 2023: 12 · 2022: 12 · 2021: 11 · 2020: 3
- FWCI
- 1.24
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Polish Ministry of Science and Higher Education (UMO-2015/19/B/NZ1/00332)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- GSK3β, glycogen synthase kinase-3β, major depressive disorder, depression pathogenesis, antidepressant response, GSK-3β inhibitors, antidepressant mechanism, upstream regulators, brain regions, depression-like behavior
- MeSH terms
- Neuroprotection, Glycogen Synthase Kinase 3 beta, Animals, Brain, Major Depressive Disorder, Hippocampus, Humans, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.